Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Chantez Bailey at [email protected].

  • February 10, 2022

    Leading Clinicians and Researchers Raise Significant Concerns about Medicare Plan to Effectively Deny Access to Alzheimer’s Treatments

    Many of the nation’s top Alzheimer’s clinicians and researchers called for the...

    Read more
  • February 10, 2022

    UsAgainstAlzheimer’s Urges CMS to Revise Plan that would Deny Medicare Coverage of FDA-approved Alzheimer’s Drugs

    A proposed plan that effectively would deny Medicare coverage for an entire...

    Read more
  • February 09, 2022

    Coalition Letter: 35 Diverse Health Advocacy Organizations Urge CMS to Prioritize Equity & Access to Alzheimer's Treatments

    The Health Equity Collaborative, together with UsAgainstAlzheimer’s, led a coalition letter to...

    Read more
  • February 09, 2022

    More Than 50 Leading Patient Organizations Send Letter Calling on Medicare to Revise Proposed National Coverage Determination

    More than 50 patient advocacy groups urged Health and Human Services Secretary Xavier Becerra to direct...

    Read more
  • February 02, 2022

    Doctors, Scientists and Patient Advocates Call for Medicare to Cover Alzheimer’s Treatments

    The draft proposal by the Centers for Medicare and Medicaid Services...

    Read more
  • January 27, 2022

    UsAgainstAlzheimer’s Welcomes Biogen’s 18 Percent Diversity Goal for U.S. Participants in Aduhelm Confirmatory Trial

    “This is an important step forward in ensuring that people of color...

    Read more
  • January 26, 2022

    UsAgainstAlzheimer’s Letter to HHS Secretary Becerra: Direct CMS to Reconsider its Draft Decision on Medicare Coverage for Alzheimer’s Drugs

    Patient advocacy group UsAgainstAlzheimer’s today urged Health and Human Services Secretary Xavier...

    Read more
  • January 19, 2022

    Myth vs. Fact: CMS Draft Decision on Alzheimer’s Drugs

    With so much misinformation surrounding the draft National Coverage Determination (NCD) from...

    Read more
  • January 13, 2022

    New Guidance Provides Clinical Recommendations to Reduce Dementia Risk

    Today, Primary Prevention Recommendations to Reduce the Risk of Cognitive Decline...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.

Read Report